IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2017 Holdings

Filed 2017-08-14 | 11 holdings | $338.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$275.0K10,13881.2%
Strongbridge Biopharma PLCSHS USDG85347105$38.6K5,394,99411.4%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$15.3K63,1834.5%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$6.1K1,623,5671.8%
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$1.5K8,9450.4%
Garrison Cap Inc(GARSUSD)COM366554103$56768,7020.2%
CM FIN IncCOM12574Q103$55155,1020.2%
Team Health Holdings IncCOM87817A107$3367,7130.1%
Adient PLC(ADNT)ORD SHSG0084W101$3104,7370.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$3091,9900.1%
Paratek Pharmaceuticals IncCOM699374302$30012,4560.1%